Tel Aviv University 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases   1 Product   1 Trial   8471 News 


«12...5253545556575859606162...6869»
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    [VIRTUAL] Disability improvement by Multiple Sclerosis Functional Composite in progressive MS patients and MRI features () -  Aug 16, 2020 - Abstract #MSDC2020MSDC_147;    
    P2
    MUCCA was not associated with improvement measures.Conclusions Improved 9HPT measures over a 12-month period correlated with baseline brain volume, while T25FW improvements correlated with baseline deep white matter T2 lesion volume. These results will inform analysis of clinical outcomes in the ongoing phase 2 clinical trial of MSC-NTF cells in progressive MS.